BALCHEM CORP (BCPC) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000009326 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 31, 2026 | $284.0M | $44.6M | $1.39 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $270.7M | $40.3M | $1.25 | Filing |
| Dec 31, 2025 | Feb 20, 2026 | $263.6M | $39.2M | $1.21 | Filing |
| Sep 30, 2025 | Oct 21, 2025 | $267.6M | $40.3M | $1.24 | Filing |
| Jun 30, 2025 | Jul 31, 2025 | $255.5M | $38.3M | $1.17 | Filing |
| Mar 31, 2025 | Apr 24, 2025 | $250.5M | $37.1M | $1.13 | Filing |
| Dec 31, 2024 | Feb 21, 2025 | $240.0M | $33.6M | $1.03 | Filing |
| Sep 30, 2024 | Oct 25, 2024 | $239.9M | $33.8M | $1.03 | Filing |
What would BALCHEM CORP have to report for its valuation to change?
At $170.53, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 23.4% a year, to $14.58. On that path the next quarter needs diluted EPS near $1.53, against $1.24 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 23.4% | 23.4% |
| EPS needed in final year | $14.58 | $14.58 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. BCPC goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.